Tricyclic antidepressants and psilocybin.
11 records in this group. 4 have published human data with psilocybin or another classic psychedelic; the rest draw on each medication's own pharmacology and label. State rules are summarized for Colorado, Oregon and New Mexico.
Overview
Reviewed 2026-10-18Tricyclic antidepressants block reuptake of noradrenaline and, to varying degrees, serotonin, and several also block 5-HT2A, the serotonin receptor psilocybin acts on. No controlled study has combined a tricyclic with psilocybin. With LSD, long-term imipramine, desipramine or clomipramine intensified the response in all 5 people who completed questionnaires (Bonson & Murphy 1996), the opposite of what 5-HT2A blockade alone would predict. Nortriptyline appears in one multi-drug case report in which psilocybin mushrooms, taken with phenelzine and other medications, produced no noticeable subjective effects (Barnett 2024).
Tricyclics have been reported to cause irregular heart rhythms, a fast heart rate and slowed cardiac conduction. The amitriptyline label also describes seizures, a drop in blood pressure on standing, and anticholinergic effects (such as dry mouth and a fast heart rate). After prolonged use, stopping suddenly can cause nausea, headache and malaise (amitriptyline prescribing information). Psilocybin has been shown to raise heart rate and blood pressure in some healthy adults (Becker 2022).
Low-dose doxepin, a tricyclic, is also used for sleep and appears on the sleep medications page. Amoxapine has dopamine-blocking activity; Colorado's rule names antipsychotic medications without defining the term, so whether it covers amoxapine is unsettled, and its record explains why.
Psilodex presents published evidence and state psilocybin regulations for information only. It is not medical advice, a screening decision, or clearance to participate. Do not stop or change a medication without talking with the prescriber.
- Bonson KR, Murphy DL. Alterations in responses to LSD in humans associated with chronic administration of tricyclic antidepressants, monoamine oxidase inhibitors or lithium. Behav Brain Res 1996;73:229–233.
- Barnett BS, Koons CJ, Van den Eynde V, et al. Hypertensive emergency secondary to combining psilocybin mushrooms, extended release dextroamphetamine-amphetamine, and tranylcypromine. J Psychoactive Drugs 2024;57(3):297–303.
- Becker AM, Holze F, Grandinetti T, et al. Acute effects of psilocybin after escitalopram or placebo pretreatment. Clin Pharmacol Ther 2022;111(4):886–895.
- Amitriptyline hydrochloride tablets prescribing information (DailyMed)
Also searched as tricyclic · TCA · tricyclics
01 What the evidence covers
Best evidence available per medication| 1 | Case reports Case reports or online surveys |
| 3 | Other psychedelic Human data with another classic psychedelic (e.g. LSD), not psilocybin; named in the text |
| 7 | No psilocybin data No psilocybin data: no human data with psilocybin or another classic psychedelic; the text draws on the medication's own pharmacology and its label or reference facts |
02 Each medication
A to ZDepression
Not studied with psilocybin; related drugs strengthened LSD's effects. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Depression, including depression with anxiety or agitation
It blocks the receptor psilocybin works through, so it may weaken psilocybin, though related drugs strengthened LSD's effects.
CO: unsettled · OR: not mentioned in rule · NM: rules not final
Obsessive-compulsive disorder (OCD)
It may weaken psilocybin, yet 5 people on it or related drugs had stronger LSD responses. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Depression
Its effect on psilocybin is unknown; with LSD, all 5 people on such antidepressants had stronger responses. Also, it raises blood pressure and heart rate.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Psychotropics
With LSD, long-term tricyclic use strengthened responses, so it may strengthen psilocybin (not studied). Also, it carries heart-rhythm and seizure risks.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Depression; Anxiety
In theory it blunts psilocybin, but related tricyclics strengthened LSD responses. Also, it sedates and affects heart rhythm; 3–6 mg acts mainly as an antihistamine.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Depression; Bedwetting in children (short-term add-on)
Its effect on psilocybin is unclear; with LSD, it or similar drugs increased the response in all 5 people interviewed.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Psychotropics
In a small LSD study, related tricyclics increased the response, so it may strengthen psilocybin. Also, it can affect heart rhythm and lower seizure threshold.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Depression
In one case, psilocybin had no noticeable effect when taken with nortriptyline plus phenelzine. Also, it can affect heart rhythm and seizure threshold.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Depression
Related tricyclic drugs increased LSD's effects, so it is expected to intensify psilocybin's effects. Stopping it suddenly after regular use can cause withdrawal.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
Depression
In lab studies it binds strongly to psilocybin's receptor, so it may weaken psilocybin. Also, it can affect heart rhythm and seizure risk.
CO: not mentioned in rule · OR: not mentioned in rule · NM: rules not final
03 Properties the records flag
Records with each flag| 11 | Anticholinergic |
| 11 | Lowers seizure threshold or carries seizure risk |
| 11 | Psychiatric reactions |
| 11 | QT-prolonging |
| 11 | Withdrawal or rebound if stopped abruptly |
| 10 | Lowers blood pressure or causes orthostasis |
| 9 | Serotonergic |
| 8 | Sedating or CNS depressant |
| 5 | Raises blood pressure or heart rate |
| 3 | Blocks 5-HT2A (may blunt effects) |
| 3 | Dehydration or electrolyte risk |
Flags describe a medication's own properties, each cited in its record. A flag is not a finding about any combination. Definitions are on the Method page.
04 State rules
Official text governsNo provision names these medications or this group. 1 unsettled.
Colorado rules 2.2(A)(6) and 2.2(A)(7) both address participants taking lithium or an antipsychotic, and the rule text does not state how the two fit together. The rule names “antipsychotic medications” without defining the term or limiting it by indication, so whether it covers this medication is unsettled; the regulator has not addressed this. Amoxapine is an antidepressant approved for depression, but it and its metabolites block dopamine D2 receptors, as antipsychotics do, and its label describes neuroleptic malignant syndrome and tardive dyskinesia. Colorado rule 2.2(A)(6) states that Facilitator licensees may not provide natural medicine services to participants taking lithium or antipsychotic medications. Under 2.2(A)(7), services may proceed only after a referral from a licensed provider (MD, DO, APN, PA or clinical facilitator), medical clearance from the participant's provider, or a consultation and risk review with a provider licensed to diagnose and treat the condition identified as a risk factor; the Facilitator documents the consultation, and where it identifies heightened risk, the rule requires a safety plan and written informed consent.
Rule 2.2(A)(9): a facilitator must tell prospective participants in writing that anyone taking a psychotropic medication identified as a risk factor on the safety screen must meet one of the 2.2(A)(7) conditions. 10 of the 11 medications in this group are psychotropic; the rule applies when one is identified as a risk factor on a participant's screen.
No provision names these medications or this group.
Rules not final; the proposed rules reviewed name no medication in this group.
05 Studies cited in this group
Records citing eachRelated classes
- Antidepressants11 shared
Records reviewed 2026-10-14 to 2026-10-25. Each row summarizes one record; the full record, with every source, opens in the browser and is not sent to the server. All classes · Browse A–Z